EPO and chronic kidney disease: Regarding medications in use, patients in the Control group received less vitamin Dsupplementation; whereas patients under conservative CKD treatment more commonlyused furosemide, and dialysis patients received more calcitriol, calcium salts,Sevelamer, and human erythropoietin (EPO).